<DOC>
	<DOCNO>NCT01956981</DOCNO>
	<brief_summary>It important decrease bleed functional endoscopic sinus surgery ( FESS ) order increase visibility surgical site . Our primary goal investigate effect magnesium sulfate dexmedetomidine use control hypotension visibility surgical site .</brief_summary>
	<brief_title>Controlled Hypotension During Functional Endoscopic Sinus Surgery</brief_title>
	<detailed_description>Background : It important decrease bleed functional endoscopic sinus surgery ( FESS ) order increase visibility surgical site . Our primary goal investigate effect magnesium sulfate dexmedetomidine use control hypotension visibility surgical site . Methods : Sixty patient age 18-65 year enrol . Patients divide two group . In magnesium sulfate group ( Group M ) patient administer 40 kg-1 magnesium sulfate 100 ml saline solution 10 minute IV load dose 10 minute induction 10-15 mgkg-1hour-1 infusion surgery . In dexmedetomidine group ( Group D ) patient administer 1 µgkg-1 dexmedetomidine 100 ml saline solution load dose 10 minute surgery 0.5-1 µgkg-1hour-1 dexmedetomidine surgery . Deliberate hypotension define mean arterial pressure ( MAP ) 60-70 mmHg .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<criteria>18 65 year schedule functional endoscopic sinus surgery Patients kidney , liver , hematological neuromuscular disease , diabetic neuropathy , know allergy history study agent . weight exceed ideal body weight 30 % , Being treat calcium channel blocker , nonsteroidal antiinflammatory drug , agent affect neuromuscular blockage , agent contraindicate controlled hypotension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>control hypotension , dexmedetomidine , magnesium sulfate .</keyword>
</DOC>